Search clinical trials for: Biomarker of Response

Total 431411 results

University of Aarhus
Aarhus University Hospital; Spinal Cord Injury Centre of Western Denmark

Unknown

The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury

Spinal Cord Injury, Acute

Denmark
Amsterdam UMC, location VUmc
Radboud University Medical Center; Leiden University Medical Center; Academisch... and other collaborators

Completed

Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Netherlands
University of Virginia
Wallace H. Coulter Foundation

Completed

Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay

Neonatal Sepsis

United States
Instituto Portugues de Oncologia, Francisco Gentil...
Linnaeus University; University of Oulu; European Commission; Polytechnic Institute... and other collaborators

Unknown

Impact of Group Psychological Interventions on Extracellular Vesicles in People Who Had Cancer (MindGAP-P)

Cancer
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Terminated

Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Central Hospital, Nancy, France

Completed

Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis

Critically Ill Patients

France
MSDx, Inc.

Completed

A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

United States
Children's Hospital Medical Center, Cincinnati

Completed

Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock

Septic Shock | Severe Sepsis

United States
Weill Medical College of Cornell University
Hamad Medical Corporation

Completed

Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis

Systemic Inflammatory Response Syndrome

United States, Qatar
Jonsson Comprehensive Cancer Center

Withdrawn

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

Stage III Prostate Adenocarcinoma

United States
University Hospital, Montpellier

Unknown

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Osteoarthritis | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Spondylitis | Sjogren's Syndrome | Gout | Scleroderma | Spinal Disease | Chondrocalcinosis

France
Clinical Research Centre, Malaysia

Unknown

A Panel of Biomarkers in Diagnosing Late-onset Neonatal Sepsis and Necrotizing Enterocolitis in Sibu Hospital (PISALONS)

Necrotizing Enterocolitis | Neonatal SEPSIS

Malaysia
Ege University

Completed

As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR (suPAR)

Septic Shock | Sepsis, Severe

Turkey
Side-Out Foundation
Translational Drug Development

Completed

Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Institut National de la Santé Et de la Recherche...

Unknown

Biomarkers and Choroidal Neovascularization (BioNéoRet)

Choroidal Neovascularization | Mineralocorticoid Excess
Universitas Diponegoro

Completed

The Effect of Fermented and Non-fermented Soy Based Food in Appetite and Satiety Biomarker Among Young Obesity

Weight Loss | Obesity, Abdominal

Indonesia
Barretos Cancer Hospital

Completed

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

Kidney Cancer | Biomarkers | Gene Expression

Brazil
USDA Grand Forks Human Nutrition Research Center

Completed

Carotenoid Response to the Intake of Vegetables and Fruits

Resonance Raman Spectroscopy for Dietary Carotenoid Intake

United States
Rup Kamal Sainju

Completed

Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI

Epilepsy | SUDEP

United States
Regeneron Pharmaceuticals
Sanofi

Completed

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

Melanoma

Korea, Republic of, Serbia, Netherlands, United Kingdom
Nilogen Oncosystems
Henry Ford Health System

Unknown

Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC (NO3DEXPL)

Non Small Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

Pancreatic Neuroendocrine Carcinoma | Multiple Endocrine Neoplasia Type 1

United States
Regeneron Pharmaceuticals
Sanofi

Completed

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)

Recurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma Neck

Korea, Republic of, United Kingdom
University of Oklahoma

Completed

DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma

Barrett's Esophagus | Esophageal Adenocarcinoma

United States
Public Health England
Cardiff University; Aneurin Bevan University Health Board

Unknown

Validation of Molecular and Protein Biomarkers in Sepsis (VAMp-sepsis)

Pneumonia | Sepsis | Cardiac Arrest | SIRS | Abdominal Sepsis

United Kingdom
University of Wisconsin, Madison
Prostate Cancer Foundation

Completed

Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

United States
Fudan University
Harbin Medical University; Liaoning Tumor Hospital & Institute

Unknown

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Adenocarcinoma | Neoadjuvant Therapy | Chemoradiotherapy | Rectal Neoplasm Malignant Carcinoma | Predictive Biomarkers

China
University Health Network, Toronto

Completed

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA (BARRIER-P)

Castration-resistant Prostate Cancer

Canada
University of Gaziantep

Completed

Effect of Cytosorb on Blood Levels of Inflammatory Biomarkers of Sepsis.

Sepsis | Cytokine Storm
Robert Ehrman

Unknown

Preclinical Detection of Sepsis Early in Hospitalized Patients Following Surgery, Injury or Severe Illness (Pre-SEPSIS)

Sepsis

United States
Azienda Ospedaliero-Universitaria Careggi

Unknown

CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION (PRIMERA)

D011471 | D064129 | D035683 | D009360 | D014408

Italy
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer

Breast Cancer

United States
University of Maryland, Baltimore
University of Maryland Greenebaum Cancer Center

Terminated

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

Breast Cancer | Neoplasm Metastasis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)

Acute Myeloid Leukemia

United States
Technical University of Munich

Terminated

BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis (Bostrip)

Psoriasis

Germany
Centre Hospitalier Universitaire Dijon

Completed

Study of Biomarkers of the Response to Biotine (BIOMARBIOT)

Multiple Sclerosis | Biotine

France
University Hospital, Basel, Switzerland
University of Erlangen-Nürnberg

Completed

Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study (COMP)

Healthy

Switzerland
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer

Small Cell Lung Carcinoma | Non-Small Cell Lung Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Janssen Pharmaceuticals

Withdrawn

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Myxoid Liposarcoma | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Round Cell Liposarcoma | Unresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma

United States
Cui Yimin

Unknown

miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment

Breast Cancer

China
VA Office of Research and Development

Completed

Brain Biomarkers of Response to Treatment for Apraxia of Speech (SPT)

Stroke | Aphasia

United States
CCTU- Cancer Theme

Unknown

Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer (ARTIST_RCC)

Carcinoma, Renal Cell
Diamant Thaci
Novartis

Completed

Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients (BIOMARKER)

Psoriasis Vulgaris

Germany
Ludwig-Maximilians - University of Munich
City of Munich

Completed

Validation of Progranulin as a Biomarker for Sepsis (PROGRANULIN)

Sepsis

Germany
ART Fertility Clinics LLC
Ansh Labs

Completed

Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment

Infertility

United Arab Emirates
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

Breast Cancer

United States
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Biomarkers in Neural Disorders

Parkinson's Disease | Myasthenia Gravis | Spinal Cord Injuries | Multiple System Atrophy | Progressive Supranuclear Palsy | Essential Tremor | Alzheimer's Disease | Diffuse Lewy Body Disease | Drug Induced Parkinson's Disease

United States
Juan González-del Castillo
Thermo Fisher Scientific, Inc

Completed

Assessment of Disease Severity, Progression and Treatment in Infected Patients Presenting to the Emergency Department (ADAPTED)

Sepsis

Spain
Abramson Cancer Center of the University of Pennsylvania

Completed

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer

United States

Search clinical trials for: Biomarker of Response

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations